Return of Organization Exempt from Income

l efile GRAPHIC p rint - DO NOT PROCESS As Filed Data - DLN: 93493320037199 Return of Organization Exempt From Income Tax O M B No 1545-0047 Form 990 Under section 501 (c), 527, or 4947( a)(1) of the Internal Revenue Code ( except black lung benefit trust or private foundation) 2008_ Department of the Open -The organization may have to use a copy of this return to satisfy state reporting requirements Treasury Inspection Internal Revenue Service A For the 2008 calendar year, or tax year beginning 01-01-2008 and ending 12-31-2008 C Name of organization D Employer identification number B Check if applicable Please Pharmaceutical Research and Manufacturers of fl Address change use IRS of America 5 3-0241 211 label or Doing Business As E Telephon e number F Name change print or PhRMA type . See (202) 835-3400 F Initial return Specific N um b er and st reet (or P 0 box if mai l is not d e l ivered to st ree t a dd ress) R oom/suite Instruc - 950 F Street NW G Gross receipts $ 280,083,770 F_ Termination tions. (-Amended return City or town, state or country, and ZIP + 4 Washington, DC 20004 F_ Application pending F Name and address of Principal Officer H(a) Is this a group return for Billy Tauzin affiliates ? F-Yes F No 950 F Street NW Suite 300 Washington , DC 20004 H(b) Are all affiliates included ? F Yes F No I Tax - exempt status F 501( c) ( 6) 1 (insert no ) (- 4947(a)(1) or F_ 527 (If "No," attach a list See instructions 3 Web site : - www phrma org H ( c) Group Exemption Number 0- K Type of organization F Corporation 1 trust F association F other I I L Year of Formation 1958 1 M State of legal domicile DE Summar y 1 Briefly describe the organization's mission or most significant activities w PhRMA's mission is winning advocacy for public policies that encourage the discovery of life-saving and life-enhancing new medicines for patients by pharmaceutical/biotechnology research companies 2 Check this box F_ if the organization discontinued its operations or disposed of more than 25% of its assets 3 Number of voting members of the governing body (Part VI, line 1a) . 3 34 4 Number of independent voting members of the governing body (Part VI, line 1b) 4 33 of 5 Total number of employees (Part V, line 2a) 5 196 6 Total number of volunteers (estimate if necessary) . 6 7a Total gross unrelated business revenue from Part VIII, line 12, column (C) 7a 0 b Net unrelated business taxable income from Form 990-T, line 34 . 7b Prior Year Current Year 8 Contributions and grants (Part VIII, line 1h) 0 0 9 Program service revenue (Part VIII, line 2g) . 245,157,601 252,497,695 N 10 Investment income (Part VIII, column (A), lines 3, 4, and 7d) . 6,950,617 1,504,015 11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 5,476 664,873 12 Total revenue-add lines 8 through 11 (must equal Part VIII, column (A), line 12) 252,113,694 254,666,583 13 Grants and similar amounts paid (Part IX, column (A), lines 1-3) 0 17,832,944 14 Benefits paid to or for members (Part IX, column (A), line 4) 0 0 15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5- 10) 43,598,842 47,839,215 16a Professional fundraising fees (Part IX, column (A), line 11e) 0 0 b (Total fundraising expenses, Part IX, column (D), line 25 0 17 Other expenses (Part IX, column (A), lines 11a-11d, 11f-24f) 211,336,678 196,271,022 18 Total expenses-add lines 13-17 (must equal Part IX, line 25, column (A)) 254,935,520 261,943,181 19 Revenue less expenses Subtract line 18 from line 12 -2,821,826 -7,276,598 Beginning of Year End of Year 20 Total assets (Part X, line 16) 129,556,187 119,634,352 21 Total liabilities (Part X, line 26) 45,202,835 65,555,413 Z606 22 Net assets or fund balances Subtract line 21 from line 20 84,353,352 54,078,939 Signature Block Under penalties of perjury, I declare that I have examined this return, including a and belief, it is true, correct, and complete Declaration of preparer (other than o Please Sign Signature of officer Here Neal Comstock Executive VP and Secretary Type or print name and title Date Preparer's Paid signature Preparer's Firm 's name (or yours Use if self-employed), Only address, and ZIP + 4 KPMG LLP 1660 International Drive McLean, VA 221024848 May the IRS discuss this return with the preparer shown above? (See instructs Form 990 (2008) Page 2 MUMV-Statement of Program Service Accomplishments (See the Instructions.) Briefly describe the organization's mission See Additional Data Table Did the organization undertake any significant program services during the year which were not listed on the prior Form 990 or 990 -EZ'' . fl Yes F No If "Yes," describe these new services on Schedule 0 Did the organization cease conducting or make significant changes in how it conducts any program services? F Yes F No If "Yes," describe these changes on Schedule 0 Describe the exempt purpose achievements for each of the organization's three largest program services by expenses Section 501 ( c)(3) and (4) organizations and 4947( a)(1) trusts are required to report the amount of grants and allocations to others, the total expenses , and revenue , if any, for each program service reported 4a (Code ) (Expenses $ including grants of $ ) (Revenue $ Public Policy Advocacy PhRMA's mission is to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by pharmaceutical/ biotechnology research companies PhRMA achieves this mission by working with, and on behalf of, its member companies before governmental and regulatory bodies in the United States and throughout the world in support of pro-patient, pro-innovation policies Specifically, PhRMA advocates for broad patient access to safe and effective medicines through a free market, without government price controls, strong intellectual property incentives, and transparent, efficient regulation and a free flow of information to patients 4b (Code (Expenses $ including grants of $ (Revenue $ Member Services In representing the country's leading pharmaceutical research and biotechnology companies, PhRMA provides a forum for member companies to participate in discussions of relevant health care issues and to develop consensus positions on matters of public policy advocacy Member companies participate in PhRMA activities through representation on the Board of Directors, Board-level committees and key issue teams, staff work groups, sections, task forces, and subcommittees Member company representatives also regularly communicate with PhRMA staff 4c (Code (Expenses $ including grants of $ (Revenue $ General Education About Biopharmaceutical Industry PhRMA disseminates information about biopharmaceutical companies, their products, and their business, scientific and philanthropic activities through a wide range of channels, including profiles, reports, principles, guidelines, fact sheets, policy papers and other resources These efforts bolster PhRMA's ability to educate and inform members of the general public as well as policymakers, the media, patients and others in the health care community about the biopharmaceutical industry and PhRMA's public policy activities in particular 4d Other program services (Describe in Schedule 0 ) (Expenses $ including grants of $ ) (Revenue $ 4e Total program service expenses $ Must equal Part IX, Line 25, column (B). Form 990 (2008) Form 990 (2008) Page 3 Li^ Checklist of Required Schedules Yes No 1 Is the organization described in section 501(c)(3) or4947(a)(1) (other than a private foundation)? If "Yes," No complete Schedule A . 1 2 Is the organization required to complete Schedule B, Schedule of Contributors? . 2 No 3 Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to Yes candidates for public office? If "Yes,"complete Schedule C, Part I . 3 4 Section 501(c)(3) organizations Did the organization engage in lobbying activities? If "Yes,"complete Schedule C, Part II . 4 5 Section 501(c)(4), 501(c)(5), and 501(c)(6) organizations Is the organization subject to the section 6033(e) 5 Yes notice and reporting requirement and proxy tax? If "Yes,"complete Schedule C, Part III 6 Did the organization maintain any donor advised funds or any accounts where donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes,"complete N o Schedule D, Part I . 6 7 Did the organization receive or hold a conservation easement, including easements to preserve open space, No the environment, historic land areas or historic structures? If "Yes,"complete Schedule D, Part 1119 7 8 Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes," N o complete Schedule D, Part III . 8 9 Did the organization report an amount in Part X, line 21, serve as a custodian for amounts not listed in Part X, or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," N o complete Schedule D, Part IV' . 9 10 Did the organization hold assets in term, permanent,or quasi-endowments? If "Yes,"complete Schedule D, Part 1/' 10 No 11 Did the organization report an amount in Part X, lines 10, 12, 13, 15, or 257 If "Yes,"complete Schedule D, . 11 Yes Parts VI, VII, VIII, IX, orXas applicable . 12 Did the organization receive an audited financial statement for the year for which it is completing this return No that was prepared in accordance with GAA P7 If "Yes," complete Schedule D, Parts XI, XII, and XIII 19 12 13 Is the organization a school as described in section 170(b)(1)(A)(ii)'' If "Yes,"completeScheduleE 13 No 14a Did the organization maintain an office, employees, or agents outside of the U S 7 .

Load more